BioMed sponsor dell’evento “Sepsi”

BioMed ha avuto il piacere di partecipare in qualità di sponsor ufficiale al corso formativo sulla Sepsi, tenutosi presso l’Aula Convegni “Missionari Saveriani” a Vicenza. L’evento, accreditato ECM e rivolto a diverse professioni sanitarie, ha...

La velocità è essenziale nella diagnosi della sepsi

In occasione della Giornata Mondiale della Sepsi, Biomed desidera sensibilizzare sull’importanza della diagnosi precoce e tempestiva per contrastare una delle principali cause di mortalità a livello globale. La sepsi, spesso definita una “killer...

PlusLife: nuovo finanziamento dalla Gates Foundation

We are pleased to announce that Pluslife has been awarded a new grant from the Bill & Melinda Gates Foundation. This significant grant will further enhance the advanced molecular Point-of-Care Testing (POCT) platform for the...

Hemoscreen for the Emergency Room

The emergency room is a fundamental pillar of the health care system, for example, with more than 17 million accesses annually in Italy, it represents a huge figure in relation to all health care services. Of these, about 43% require a CBC test,...

PlusLife TongueSwab MTB at The Union Conference 2023

On Thursday, November 16, in Paris, Dr. Zhou Songyang, founder of Pluslife, together with CEO Chong Chen, attended the Union World Conference on Lung Health. The 2023 theme, 'Turning Evidence into Practice,' reflects...

Hemoscreen in cancer treatment centers

HemoScreen, among the leaders in modern point-of-care CBC (complete blood count) equipment, is revolutionizing cancer patient care and transforming the overall treatment experience in infusion centers. Here are the reasons why HemoScreen...